BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Csepregi A, Röcken C, Treiber G, Malfertheiner P. Budesonide induces complete remission in autoimmune hepatitis. World J Gastroenterol 2006; 12(9): 1362-1366 [PMID: 16552802 DOI: 10.3748/wjg.v12.i9.1362]
URL: https://www.wjgnet.com/1007-9327/full/v12/i9/1362.htm
(0) (0) (6643) (54)
Number Citing Articles
1
Albert J Czaja. Clinical Features, Differential Diagnosis and Treatment of Autoimmune Hepatitis in the Elderly. Drugs & Aging 2008; 25(3) doi: 10.2165/00002512-200825030-00005
2
Michael P. Manns, Elmar Jaeckel, Richard Taubert. Budesonide in Autoimmune Hepatitis: The Right Drug at the Right Time for the Right Patient. Clinical Gastroenterology and Hepatology 2018; 16(2) doi: 10.1016/j.cgh.2017.11.003
3
Albert J. Czaja, Michael P. Manns. Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis. Gastroenterology 2010; 139(1) doi: 10.1053/j.gastro.2010.04.053
4
Ignasi Olivas, Marina Cobreros, María-Carlota Londoño, Álvaro Díaz-González. Budesonide in the first line treatment of patients with autoimmune hepatitis. Gastroenterología y Hepatología 2022; 45(7) doi: 10.1016/j.gastrohep.2021.11.012
5
Marina G Silveira, Keith D Lindor. Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis. Expert Opinion on Pharmacotherapy 2014; 15(3) doi: 10.1517/14656566.2014.873404
6
Khurram Bari, Shimul A. Shah, Tiffany E. Kaiser, Robert M. Cohen, Nadeem Anwar, David Kleesattel, Kenneth E. Sherman. Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a Trial. Liver Transplantation 2020; 26(11) doi: 10.1002/lt.25837
7
Rima Fawaz. Pediatric Gastrointestinal and Liver Disease. 2026;  doi: 10.1016/B978-0-443-11760-2.00076-8
8
Marlyn J Mayo. Management of autoimmune hepatitis. Current Opinion in Gastroenterology 2011; 27(3) doi: 10.1097/MOG.0b013e3283457ce0
9
Rima Fawaz, Maureen M. Jonas. Pediatric Gastrointestinal and Liver Disease. 2011;  doi: 10.1016/B978-1-4377-0774-8.10075-2
10
Albert J. Czaja. Advances in the Current Treatment of Autoimmune Hepatitis. Digestive Diseases and Sciences 2012; 57(8) doi: 10.1007/s10620-012-2151-2
11
A. D. YEOMAN, M. S. LONGHI, M. A. HENEGHAN. Review article: the modern management of autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 2010; 31(8) doi: 10.1111/j.1365-2036.2010.04241.x
12
Michael A Heneghan, Andrew D Yeoman, Sumita Verma, Alastair D Smith, Maria Serena Longhi. Autoimmune hepatitis. The Lancet 2013; 382(9902) doi: 10.1016/S0140-6736(12)62163-1
13
Aldo J. Montano-Loza. Autoimmune Hepatitis. 2012;  doi: 10.1007/978-1-60761-569-9_6
14
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. Journal of Hepatology 2009; 51(2) doi: 10.1016/j.jhep.2009.04.009
15
Guiqiang Wang, Atsushi Tanaka, Hong Zhao, Jidong Jia, Xiong Ma, Kenichi Harada, Fu-Sheng Wang, Lai Wei, Qixia Wang, Ying Sun, Yuan Hong, Huiying Rao, Cumali Efe, George Lau, Diana Payawal, Rino Gani, Keith Lindor, Wasim Jafri, Masao Omata, Shiv Kumar Sarin. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatology International 2021; 15(2) doi: 10.1007/s12072-021-10170-1
16
Kenneth R Snider, Teresa G Potter. Budesonide for the Treatment of Autoimmune Hepatitis. Annals of Pharmacotherapy 2011; 45(9) doi: 10.1345/aph.1Q244
17
Saumya Pathak, Deepak Kamat. Autoimmune Hepatitis in Children. Pediatric Annals 2018; 47(2) doi: 10.3928/19382359-20180126-01
18
Aldo J Montano Loza, Albert J Czaja. Current therapy for autoimmune hepatitis. Nature Clinical Practice Gastroenterology & Hepatology 2007; 4(4) doi: 10.1038/ncpgasthep0768
19
V. Selvarajah, A. J. Montano‐Loza, A. J. Czaja. Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Alimentary Pharmacology & Therapeutics 2012; 36(8) doi: 10.1111/apt.12042
20
Claudia Della Corte, Antonella Mosca, Andrea Vania, Arianna Alterio, Anna Alisi, Valerio Nobili. Pediatric liver diseases: current challenges and future perspectives. Expert Review of Gastroenterology & Hepatology 2016; 10(2) doi: 10.1586/17474124.2016.1129274
21
Edward L Krawitt. Clinical features and management of autoimmune hepatitis. World Journal of Gastroenterology 2008; 14(21): 3301-3305 doi: 10.3748/wjg.14.3301
22
Ignasi Olivas, Marina Cobreros, María-Carlota Londoño, Álvaro Díaz-González. Budesonide in the first line treatment of patients with autoimmune hepatitis. Gastroenterología y Hepatología (English Edition) 2022; 45(7) doi: 10.1016/j.gastre.2021.11.003
23
Stefanie Langreen, Nathalie Pauer, Eva D. Pfister, Norman Junge, Ulrich Baumann, Omid Madadi‐Sanjani, Claus Petersen, Jens Dingemann, Nagoud Schukfeh. Rectal budesonide: A potential game changer after Kasai hepatoportoenterostomy. Journal of Pediatric Gastroenterology and Nutrition 2025; 81(3) doi: 10.1002/jpn3.70147
24
Cumali Efe, Ersan Ozaslan, Taylan Kav, Tugrul Purnak, Ali Shorbagi, Ozgür Ozkayar, Alexandra Heurgue Berlot, Cenk Sökmensuer, Paolo Muratori. Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome. Autoimmunity Reviews 2012; 11(5) doi: 10.1016/j.autrev.2011.09.006
25
Roger D. Soloway, Alexander T. Hewlett. The medical treatment for autoimmune hepatitis through corticosteroid to new immunosuppressive agents: A concise review. Annals of Hepatology 2007; 6(4) doi: 10.1016/S1665-2681(19)31899-X
26
Aldo J. Montano‐Loza, Herschel A. Carpenter, Albert J. Czaja. Consequences of treatment withdrawal in type 1 autoimmune hepatitis. Liver International 2007; 27(4) doi: 10.1111/j.1478-3231.2007.01444.x
27
Dermot Gleeson, Michael A Heneghan. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut 2011; 60(12) doi: 10.1136/gut.2010.235259
28
Yan Zhang, Jie Lu, Weiqi Dai, Fan Wang, Miao Shen, Jing Yang, Rong Zhu, Huawei Zhang, Kan Chen, Ping Cheng, Lei He, Chengfen Wang, Ling Xu, Yingqun Zhou, Chuanyong Guo. Combination Therapy of Ursodeoxycholic Acid and Corticosteroids for Primary Biliary Cirrhosis with Features of Autoimmune Hepatitis: A Meta-Analysis. Gastroenterology Research and Practice 2013; 2013 doi: 10.1155/2013/490731
29
Lise Lotte Gluud, Eva Efsen Dahl, Ahmed Al-Rifai, Martin Prince. Medical treatments for autoimmune hepatitis. Cochrane Database of Systematic Reviews 2009;  doi: 10.1002/14651858.CD004543.pub2
30
Claudia Della Corte, Maria Rita Sartorelli, Carmen Donatella Sindoni, Elia Girolami, Luigi Giovannelli, Donatella Comparcola, Valerio Nobili. Autoimmune hepatitis in children. European Journal of Gastroenterology & Hepatology 2012; 24(7) doi: 10.1097/MEG.0b013e328353750c
31
Atsushi Tanaka. Treatment of autoimmune hepatitis -approach to the establishment of evidence-based guidelines. Kanzo 2006; 47(5) doi: 10.2957/kanzo.47.233
32
Kareem Sassi, Jose M. Nieto, Sammy Saab. Transplantation of the Liver. 2015;  doi: 10.1016/B978-1-4557-0268-8.00015-4
33
Moritz Peiseler, Tina Liebscher, Marcial Sebode, Roman Zenouzi, Johannes Hartl, Hanno Ehlken, Nadine Pannicke, Christina Weiler-Normann, Ansgar W. Lohse, Christoph Schramm. Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 2018; 16(2) doi: 10.1016/j.cgh.2016.12.040
34
Syed Rizvi, Samer Gawrieh. Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management. Drugs & Aging 2018; 35(7) doi: 10.1007/s40266-018-0556-0
35
EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 2015; 63(4) doi: 10.1016/j.jhep.2015.06.030
36
Minkoulou Danielle, Yongfeng Yang. Review of Autoimmune Hepatitis: Diagnosis and Treatment. Open Journal of Gastroenterology 2018; 8(03) doi: 10.4236/ojgas.2018.83006
37
Antal Csepregi, Peter Malfertheiner. Do we need alternative treatment options for autoimmune hepatitis?. Current Gastroenterology Reports 2006; 8(3) doi: 10.1007/s11894-006-0069-6
38
Rima Fawaz, Maureen M. Jonas. Pediatric Gastrointestinal and Liver Disease. 2021;  doi: 10.1016/B978-0-323-67293-1.00075-X
39
Rubén Peña-Vélez, Enory Almanza-Miranda. Hepatitis autoinmune en la edad pediátrica. Boletín Médico del Hospital Infantil de México 2017; 74(5) doi: 10.1016/j.bmhimx.2017.05.004
40
A. J. Czaja. Review article: the management of autoimmune hepatitis beyond consensus guidelines. Alimentary Pharmacology & Therapeutics 2013; 38(4) doi: 10.1111/apt.12381
41
Walter EB Sipe, Philip Rosenthal. Autoimmune hepatitis in children: diagnosis, pathology and treatment. Expert Review of Clinical Immunology 2007; 3(2) doi: 10.1586/1744666X.3.2.159
42
Natanie J. Anilovich. Oral budesonide is an effective alternative to prednisone for treatment of autoimmune hepatitis. Clinical Research In Practice: The Journal of Team Hippocrates 2021; 7(2) doi: 10.22237/crp/1622160960
43
Tanima Bose. Bitter correlationship between autoimmune hepatitis and smoking. Medical Hypotheses 2015; 84(2) doi: 10.1016/j.mehy.2014.12.006
44
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World Journal of Gastroenterology 2017; 23(33): 6030-6048 doi: 10.3748/wjg.v23.i33.6030
45
Arunansu Talukdar, Dibbendhu Khanra, Kabita Mukherjee, Manjari Saha. Autoimmune hepatitis in a teenage boy: ‘overlap’ or ‘outlier’ syndrome—dilemma for internists. BMJ Case Reports 2013; 2013 doi: 10.1136/bcr-2012-008335
46
Kirsten Muri Boberg. Autoimmune Hepatitis. 2012;  doi: 10.1007/978-1-60761-569-9_12
47
Nora Cazzagon, Olivier Chazouillères. Liver Immunology. 2020;  doi: 10.1007/978-3-030-51709-0_24
48
P. J. Trivedi, G. M. Hirschfield. Review article: overlap syndromes and autoimmune liver disease. Alimentary Pharmacology & Therapeutics 2012; 36(6) doi: 10.1111/j.1365-2036.2012.05223.x
49
T. Zvyagintseva, A. Chernobay. Autoimmune hepatitis. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2016; 2016(1) doi: 10.15407/internalmed2016.01.033
50
David C. Wolf, Lizza Bojito, Marcelo Facciuto, Edward Lebovics. Mycophenolate Mofetil for Autoimmune Hepatitis: A Single Practice Experience. Digestive Diseases and Sciences 2009; 54(11) doi: 10.1007/s10620-008-0632-0
51
Dinesh Jothimani, Matthew E Cramp, Jonathon D Mitchell, Tim J S Cross. Treatment of autoimmune hepatitis: A review of current and evolving therapies. Journal of Gastroenterology and Hepatology 2011; 26(4) doi: 10.1111/j.1440-1746.2010.06579.x
52
Albert J Czaja. Drug choices in autoimmune hepatitis: Part A – steroids. Expert Review of Gastroenterology & Hepatology 2012; 6(5) doi: 10.1586/egh.12.40
53
Luigi Muratori, Paolo Muratori, Alessandro Granito, Giorgios Pappas, Fabio Cassani, Marco Lenzi. Current topics in autoimmune hepatitis. Digestive and Liver Disease 2010; 42(11) doi: 10.1016/j.dld.2010.05.019
54
Christian Rust, Ulrich Beuers. Overlap syndromes among autoimmune liver diseases. World Journal of Gastroenterology 2008; 14(21): 3368-3373 doi: 10.3748/wjg.14.3368
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.